Disease therapy using a tolerogenic pharmaceutical preparation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10653758
APP PUB NO 20150343039A1
SERIAL NO

14759452

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein is a method for treating or preventing a pathological immune response comprising administering a supernatant obtainable from co-culture of phagocytes with apoptotic cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)101 RUE DE TOLBIAC PARIS 75013
UNIVERSITE DE FRANCHE-COMTE25000 BESANÇON
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE BESANCON2 PLACE SAINT-JACQUES BESANÇON CEDEX 25030
ETABLISSMENT FRANCAIS DU SANG20 AVENUE DU STADE DE FRANCE LA PLAINE SAINT DENIS 93210

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bonnefoy, Francis Besancon, FR 7 50
Perruche, Sylvain Besancon, FR 3 2
Saas, Philippe Besancon, FR 3 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 19, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 19, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00